Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

VeriSIM Expects AI Use To Trim Margin For Failure In OTC Switches, Help Boost Revenue Margins

Mar 21 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process And For Consumers

Jun 28 2022

Petros Pharma Introduces AI As ACNU Option In Research For OTC Switch Of Stendra ED Drug

Feb 19 2024

Light Still On For Switches After Pfizer Pulls Plug On OTC <em>Lipitor</em>

Aug 03 2015

When Using Artificial Intelligence In Pharma R&D, Start With Identifying Problem To Solve

Mar 21 2024

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

Jul 17 2018

Additional Topics

International United States Artificial Intelligence Prescription To OTC Switch FDA Business Strategies Commercial Compliance Consumer Drug Approval Standards Drug Safety Ingredients Manufacturing OTC Drugs Policy Regulation Research & Development

More from Digital Technologies

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window